Microglia
Multiple roles in surveillance, circuit shaping, and response to injury
Abstract
Microglial cells are the immune cells in the CNS and represent approximately 10% of the total brain cell population. Their morphologic characterization by Pio del Rio-Hortega was first published almost a century ago, but the understanding of their function in the normal and injured CNS is still incomplete. Classically, microglia have been classified into 2 main types: “resting” microglia, with a ramified morphology, present in the uninjured CNS; and “activated” microglia, with an amoeboid morphology, present at the sites of injury. However, morphologic, molecular, and genetic studies indicate that this subdivision is a misleading oversimplification. Resting microglia actively survey their environment; activated microglia constitute a heterogeneous population that dynamically changes in phenotype depending on the type of stimulus and microenvironment, participating not only in mechanisms of injury but also in neuroprotection, repair, and circuit refinement in the CNS. The primary role of microglia is therefore to maintain cellular, synaptic, and myelin homeostasis both during development and normal function of the CNS and in response to CNS injury. Microglia have been implicated in mechanisms of CNS trauma, stroke, infection, demyelination, neoplasm, and neurodegeneration. Microglial dysfunction may also contribute to genetic neurobehavioral disorders, such as Rett syndrome. There are several comprehensive reviews on all these topics.1–12
Get full access to this article
View all available purchase options and get full access to this article.
REFERENCES
1.
Hanisch UK, Kettenmann H. Microglia: active sensor and versatile effector cells in the normal and pathologic brain. Nat Neurosci 2007;10:1387–1394.
2.
Ransohoff RM, Cardona AE. The myeloid cells of the central nervous system parenchyma. Nature 2010;468:253–262.
3.
Tremblay ME, Stevens B, Sierra A, Wake H, Bessis A, Nimmerjahn A. The role of microglia in the healthy brain. J Neurosci 2011;31:16064–16069.
4.
Kettenmann H, Hanisch UK, Noda M, Verkhratsky A. Physiology of microglia. Physiol Rev 2011;91:461–553.
5.
Hanisch UK. Proteins in microglial activation: inputs and outputs by subsets. Curr Protein Pept Sci 2013;14:3–15.
6.
Wake H, Moorhouse AJ, Miyamoto A, Nabekura J. Microglia: actively surveying and shaping neuronal circuit structure and function. Trends Neurosci 2013;36:209–217.
7.
Kettenmann H, Kirchhoff F, Verkhratsky A. Microglia: new roles for the synaptic stripper. Neuron 2013;77:10–18.
8.
Lucin KM, Wyss-Coray T. Immune activation in brain aging and neurodegeneration: too much or too little? Neuron 2009;64:110–122.
9.
Wong WT. Microglial aging in the healthy CNS: phenotypes, drivers, and rejuvenation. Front Cell Neurosci 2013;7:22.
10.
Block ML, Zecca L, Hong JS. Microglia-mediated neurotoxicity: uncovering the molecular mechanisms. Nat Rev Neurosci 2007;8:57–69.
11.
Perry VH, Nicoll JA, Holmes C. Microglia in neurodegenerative disease. Nat Rev Neurol 2010;6:193–201.
12.
Boche D, Perry VH, Nicoll JA. Review: activation patterns of microglia and their identification in the human brain. Neuropathol Appl Neurobiol 2013;39:3–18.
13.
Chan WY, Kohsaka S, Rezaie P. The origin and cell lineage of microglia: new concepts. Brain Res Rev 2007;53:344–354.
14.
Mittelbronn M, Dietz K, Schluesener HJ, Meyermann R. Local distribution of microglia in the normal adult human central nervous system differs by up to one order of magnitude. Acta Neuropathol 2001;101:249–255.
15.
Ajami B, Bennett JL, Krieger C, Tetzlaff W, Rossi FM. Local self-renewal can sustain CNS microglia maintenance and function throughout adult life. Nat Neurosci 2007;10:1538–1543.
16.
Nimmerjahn A, Kirchhoff F, Helmchen F. Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo. Science 2005;308:1314–1318.
17.
Mosser DM, Edwards JP. Exploring the full spectrum of macrophage activation. Nat Rev Immunol 2008;8:958–969.
18.
Ransohoff RM, Perry VH. Microglial physiology: unique stimuli, specialized responses. Annu Rev Immunol 2009;27:119–145.
19.
Skaper SD. Ion channels on microglia: therapeutic targets for neuroprotection. CNS Neurol Disord Drug Targets 2011;10:44–56.
20.
Bajramovic JJ. Regulation of innate immune responses in the central nervous system. CNS Neurol Disord Drug Targets 2011;10:4–24.
21.
Lee M. Neurotransmitters and microglial-mediated neuroinflammation. Curr Protein Pept Sci 2013;14:21–32.
22.
Zabel MK, Kirsch WM. From development to dysfunction: microglia and the complement cascade in CNS homeostasis. Ageing Res Rev Epub 2013 Feb 16.
23.
Bisogno T, Di Marzo V. Cannabinoid receptors and endocannabinoids: role in neuroinflammatory and neurodegenerative disorders. CNS Neurol Disord Drug Targets 2010;9:564–573.
24.
Tremblay ME. The role of microglia at synapses in the healthy CNS: novel insights from recent imaging studies. Neuron Glia Biol 2011;7:67–76.
25.
Fontainhas AM, Wang M, Liang KJ, et al. Microglial morphology and dynamic behavior is regulated by ionotropic glutamatergic and GABAergic neurotransmission. PLoS One 2011;6:e15973.
26.
Wake H, Moorhouse AJ, Nabekura J. Functions of microglia in the central nervous system: beyond the immune response. Neuron Glia Biol 2011;7:47–53.
27.
Montero M, Gonzalez B, Zimmer J. Immunotoxic depletion of microglia in mouse hippocampal slice cultures enhances ischemia-like neurodegeneration. Brain Res 2009;1291:140–152.
28.
Vinet J, Weering HR, Heinrich A, et al. Neuroprotective function for ramified microglia in hippocampal excitotoxicity. J Neuroinflammation 2012;9:27.
29.
Boscia F, Esposito CL, Di Crisci A, de Franciscis V, Annunziato L, Cerchia L. GDNF selectively induces microglial activation and neuronal survival in CA1/CA3 hippocampal regions exposed to NMDA insult through Ret/ERK signalling. PLoS One 2009;4:e6486.
30.
Persson M, Ronnback L. Microglial self-defence mediated through GLT-1 and glutathione. Amino Acids 2012;42:207–219.
31.
Blinzinger K, Kreutzberg G. Displacement of synaptic terminals from regenerating motoneurons by microglial cells. Z Zellforsch Mikrosk Anat 1968;85:145–157.
32.
Schiefer J, Kampe K, Dodt HU, Zieglgansberger W, Kreutzberg GW. Microglial motility in the rat facial nucleus following peripheral axotomy. J Neurocytol 1999;28:439–453.
33.
Trapp BD, Wujek JR, Criste GA, et al. Evidence for synaptic stripping by cortical microglia. Glia 2007;55:360–368.
34.
Yamada J, Nakanishi H, Jinno S. Differential involvement of perineuronal astrocytes and microglia in synaptic stripping after hypoglossal axotomy. Neuroscience 2011;182:1–10.
35.
Fitzner D, Schnaars M, van Rossum D, et al. Selective transfer of exosomes from oligodendrocytes to microglia by macropinocytosis. J Cell Sci 2011;124:447–458.
36.
Kreutzberg GW. Microglia: a sensor for pathological events in the CNS. Trends Neurosci 1996;19:312–318.
37.
Banati RB. Visualising microglial activation in vivo. Glia 2002;40:206–217.
38.
Schwartz M, Butovsky O, Bruck W, Hanisch UK. Microglial phenotype: is the commitment reversible? Trends Neurosci 2006;29:68–74.
39.
Mandrekar-Colucci S, Karlo JC, Landreth GE. Mechanisms underlying the rapid peroxisome proliferator-activated receptor-gamma-mediated amyloid clearance and reversal of cognitive deficits in a murine model of Alzheimer's disease. J Neurosci 2012;32:10117–10128.
40.
Marin-Teva JL, Cuadros MA, Martin-Oliva D, Navascues J. Microglia and neuronal cell death. Neuron Glia Biol 2011;7:25–40.
41.
Choi SH, Veeraraghavalu K, Lazarov O, et al. Non-cell-autonomous effects of presenilin 1 variants on enrichment-mediated hippocampal progenitor cell proliferation and differentiation. Neuron 2008;59:568–580.
42.
Stevens B, Allen NJ, Vazquez LE, et al. The classical complement cascade mediates CNS synapse elimination. Cell 2007;131:1164–1178.
43.
Schafer DP, Lehrman EK, Kautzman AG, et al. Microglia sculpt postnatal neural circuits in an activity and complement-dependent manner. Neuron 2012;74:691–705.
44.
Stephan AH, Barres BA, Stevens B. The complement system: an unexpected role in synaptic pruning during development and disease. Annu Rev Neurosci 2012;35:369–389.
45.
McCoy MK, Tansey MG. TNF signaling inhibition in the CNS: implications for normal brain function and neurodegenerative disease. J Neuroinflammation 2008;5:45.
46.
Stellwagen D, Malenka RC. Synaptic scaling mediated by glial TNF-alpha. Nature 2006;440:1054–1059.
47.
Pascual O, Ben Achour S, Rostaing P, Triller A, Bessis A. Microglia activation triggers astrocyte-mediated modulation of excitatory neurotransmission. Proc Natl Acad Sci USA 2012;109:E197–E205.
48.
Trang T, Beggs S, Salter MW. Brain-derived neurotrophic factor from microglia: a molecular substrate for neuropathic pain. Neuron Glia Biol 2011;7:99–108.
49.
Damani MR, Zhao L, Fontainhas AM, Amaral J, Fariss RN, Wong WT. Age-related alterations in the dynamic behavior of microglia. Aging Cell 2011;10:263–276.
50.
Streit WJ, Xue QS. The Brain's aging immune system. Aging Dis 2010;1:254–261.
51.
Morrison JH, Baxter MG. The ageing cortical synapse: hallmarks and implications for cognitive decline. Nat Rev Neurosci 2012;13:240–250.
52.
Rubinsztein DC, DiFiglia M, Heintz N, et al. Autophagy and its possible roles in nervous system diseases, damage and repair. Autophagy 2005;1:11–22.
53.
Schuitemaker A, van der Doef TF, Boellaard R, et al. Microglial activation in healthy aging. Neurobiol Aging 2012;33:1067–1072.
54.
Bachstetter AD, Morganti JM, Jernberg J, et al. Fractalkine and CX 3 CR1 regulate hippocampal neurogenesis in adult and aged rats. Neurobiol Aging 2011;32:2030–2044.
55.
McPherson CA, Aoyama M, Harry GJ. Interleukin (IL)-1 and IL-6 regulation of neural progenitor cell proliferation with hippocampal injury: differential regulatory pathways in the subgranular zone (SGZ) of the adolescent and mature mouse brain. Brain Behav Immun 2011;25:850–862.
56.
Carpentier PA, Palmer TD. Immune influence on adult neural stem cell regulation and function. Neuron 2009;64:79–92.
57.
Annunziato L, Boscia F, Pignataro G. Ionic transporter activity in astrocytes, microglia, and oligodendrocytes during brain ischemia. J Cereb Blood Flow Metab 2013;33:969–982.
58.
Hernandez-Ontiveros DG, Tajiri N, Acosta S, Giunta B, Tan J, Borlongan CV. Microglia activation as a biomarker for traumatic brain injury. Front Neurol 2013;4:30.
59.
Lassmann H, Bruck W, Lucchinetti CF. The immunopathology of multiple sclerosis: an overview. Brain Pathol 2007;17:210–218.
60.
Furr SR, Marriott I. Viral CNS infections: role of glial pattern recognition receptors in neuroinflammation. Front Microbiol 2012;3:201.
61.
Grovit-Ferbas K, Harris-White ME. Thinking about HIV: the intersection of virus, neuroinflammation and cognitive dysfunction. Immunol Res 2010;48:40–58.
62.
Li W, Graeber MB. The molecular profile of microglia under the influence of glioma. Neuro Oncol 2012;14:958–978.
63.
Komohara Y, Horlad H, Ohnishi K, et al. Importance of direct macrophage-tumor cell interaction on progression of human glioma. Cancer Sci 2012;103:2165–2172.
64.
Ye XZ, Xu SL, Xin YH, et al. Tumor-associated microglia/macrophages enhance the invasion of glioma stem-like cells via TGF-beta1 signaling pathway. J Immunol 2012;189:444–453.
65.
Griffin WS. Neuroinflammatory cytokine signaling and Alzheimer's disease. N Engl J Med 2013;368:770–771.
66.
Smith C, Gentleman SM, Leclercq PD, et al. The neuroinflammatory response in humans after traumatic brain injury. Neuropathol Appl Neurobiol Epub 2012 Dec 11.
67.
Hernangomez M, Mestre L, Correa FG, et al. CD200-CD200R1 interaction contributes to neuroprotective effects of anandamide on experimentally induced inflammation. Glia 2012;60:1437–1450.
68.
Olah M, Amor S, Brouwer N, et al. Identification of a microglia phenotype supportive of remyelination. Glia 2012;60:306–321.
69.
Voss EV, Skuljec J, Gudi V, et al. Characterisation of microglia during de- and remyelination: can they create a repair promoting environment? Neurobiol Dis 2012;45:519–528.
70.
Gomez-Nicola D, Fransen NL, Suzzi S, Perry VH. Regulation of microglial proliferation during chronic neurodegeneration. J Neurosci 2013;33:2481–2493.
71.
Perry VH, O'Connor V. The role of microglia in synaptic stripping and synaptic degeneration: a revised perspective. ASN Neuro 2010;2:e00047.
72.
Solito E, Sastre M. Microglia function in Alzheimer's disease. Front Pharmacol 2012;3:14.
73.
Watson MB, Richter F, Lee SK, et al. Regionally-specific microglial activation in young mice over-expressing human wildtype alpha-synuclein. Exp Neurol 2012;237:318–334.
74.
Doorn KJ, Lucassen PJ, Boddeke HW, et al. Emerging roles of microglial activation and non-motor symptoms in Parkinson's disease. Prog Neurobiol 2012;98:222–238.
75.
Beraud D, Maguire-Zeiss KA. Misfolded alpha-synuclein and Toll-like receptors: therapeutic targets for Parkinson's disease. Parkinsonism Relat Disord 2012;18(suppl 1):S17–S20.
76.
Ishizawa K, Komori T, Sasaki S, Arai N, Mizutani T, Hirose T. Microglial activation parallels system degeneration in multiple system atrophy. J Neuropathol Exp Neurol 2004;63:43–52.
77.
Phani S, Re DB, Przedborski S. The role of the innate immune system in ALS. Front Pharmacol 2012;3:150.
78.
Perry VH, Cunningham C, Boche D. Atypical inflammation in the central nervous system in prion disease. Curr Opin Neurol 2002;15:349–354.
79.
Guerreiro R, Wojtas A, Bras J, et al. TREM2 variants in Alzheimer's disease. N Engl J Med 2013;368:117–127.
80.
Hughes MM, Field RH, Perry VH, Murray CL, Cunningham C. Microglia in the degenerating brain are capable of phagocytosis of beads and of apoptotic cells, but do not efficiently remove PrPSc, even upon LPS stimulation. Glia 2010;58:2017–2030.
81.
Krabbe G, Halle A, Matyash V, et al. Functional impairment of microglia coincides with Beta-amyloid deposition in mice with Alzheimer-like pathology. PLoS One 2013;8:e60921.
82.
Ku MC, Wolf SA, Respondek D, et al. GDNF mediates glioblastoma-induced microglia attraction but not astrogliosis. Acta Neuropathol 2013;125:609–620.
83.
Derecki NC, Cronk JC, Kipnis J. The role of microglia in brain maintenance: implications for Rett syndrome. Trends Immunol 2013;34:144–150.
Information & Authors
Information
Published In
Copyright
© 2013 American Academy of Neurology.
Publication History
Published online: August 14, 2013
Published in print: September 17, 2013
Disclosure
The author reports no disclosures relevant to the manuscript. Go to Neurology.org for full disclosures.
Authors
Metrics & Citations
Metrics
Citation information is sourced from Crossref Cited-by service.
Citations
Download Citations
If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Select your manager software from the list below and click Download.
Cited By
- Glial Perturbation in Metal Neurotoxicity: Implications for Brain Disorders, Neuroglia, 6, 1, (4), (2025).https://doi.org/10.3390/neuroglia6010004
- The Neuroimmunological Nexus of Multiple Sclerosis: Deciphering the Microglial Transcriptomic Tapestry, Neuroglia, 5, 3, (234-253), (2024).https://doi.org/10.3390/neuroglia5030017
- Adolescent alcohol drinking interaction with the gut microbiome: implications for adult alcohol use disorder, Advances in Drug and Alcohol Research, 4, (2024).https://doi.org/10.3389/adar.2024.11881
- Microglia in the aged brain develop a hypoactive molecular phenotype after surgery, Journal of Neuroinflammation, 21, 1, (2024).https://doi.org/10.1186/s12974-024-03307-0
- Insertional effect following electrode implantation: an underreported but important phenomenon, Brain Communications, 6, 3, (2024).https://doi.org/10.1093/braincomms/fcae093
- Echinatin protects from ischemic brain injury by attenuating NLRP3-related neuroinflammation, Neurochemistry International, 175, (105676), (2024).https://doi.org/10.1016/j.neuint.2024.105676
- Surface electrical stimulation of the auditory cortex preserves efferent medial olivocochlear neurons and reduces cochlear traits of age-related hearing loss, Hearing Research, 447, (109008), (2024).https://doi.org/10.1016/j.heares.2024.109008
- The neurotransmitter puzzle of Alzheimer's: Dissecting mechanisms and exploring therapeutic horizons, Brain Research, 1829, (148797), (2024).https://doi.org/10.1016/j.brainres.2024.148797
- Role of astrocyte senescence regulated by the non– canonical autophagy in the neuroinflammation associated to cerebral malaria, Brain, Behavior, and Immunity, 117, (20-35), (2024).https://doi.org/10.1016/j.bbi.2023.12.030
- Akkermansia muciniphila-derived small extracellular vesicles attenuate intestinal ischemia-reperfusion-induced postoperative cognitive dysfunction by suppressing microglia activation via the TLR2/4 signaling, Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1871, 2, (119630), (2024).https://doi.org/10.1016/j.bbamcr.2023.119630
- See more
Loading...
View Options
Login options
Check if you have access through your login credentials or your institution to get full access on this article.
Personal login Institutional LoginPurchase Options
The neurology.org payment platform is currently offline. Our technical team is working as quickly as possible to restore service.
If you need immediate support or to place an order, please call or email customer service:
- 1-800-638-3030 for U.S. customers - 8:30 - 7 pm ET (M-F)
- 1-301-223-2300 for customers outside the U.S. - 8:30 - 7 pm ET (M-F)
- [email protected]
We appreciate your patience during this time and apologize for any inconvenience.
1. Benarroch EE. Microglia: Multiple roles in surveillance, circuit shaping, and response to injury. Neurology 2013;81:1079-1088. 2. Rademakers R, Baker M, Nicholson AM, et al. Mutations in the colony stimulating factor 1 receptor (CSF1R) gene cause hereditary diffuse leukoencephalopathy with spheroids. Nat Genet 2012;44:200-205. 3. Sundal C, Lash J, Aasly J, et al. Hereditary diffuse leukoencephalopathy with axonal spheroids (HDLS): a misdiagnosed disease entity. J Neurol Sci 2012;314:130-137. 4. Zelante T, Ricciardi-Castagnoli P. The yin-yang nature of CSF1R-binding cytokines. Nature immunology 2012;13:717-719.